Envejecimiento y Fragilidad en el paciente con infección por VIH

Palabras clave: HIV, Fragilidad, Función física, Envejecimiento

Resumen

El presente trabajo aborda el concepto de fragilidad, la epidemiología en población general y en pacientes que viven con infección por VIH (PVCV) y su importancia. Se describen los principales instrumentos que detectan y cuantifican la fragilidad y analiza el impacto que la fragilidad tiene en la morbi-mortalidad. Se estudian cuáles son las estrategias terapéuticas ante la fragilidad haciendo hincapié en la terapia multicomponente. Por último, esta revisión se centra en la fragilidad en el paciente con infección por VIH. Se estudia la prevalencia y las variables asociadas con la fragilidad en esta población específica. Se señalan las dificultades del estudio en este grupo de pacientes dado los problemas metodológicos en el diagnóstico con escalas no validadas y se insiste en la necesidad de una herramienta que de forma rápida permita evaluar la fragilidad para alertar de una comorbilidad, o para iniciar un programa de intervención multidisciplinar.

Citas

Fried LP, Tangen CM, Walston J, et al. Frailty in older adults: evidence for a phenotype. The Journals of Gerontology Series A: Biological Sciences and Medical Sciences 2001;56:M146-56.

Rockwood K, Song X, MacKnight C, et al. A global clinical measure of fitness and frailty in elderly people. Canadian Medical Association Journal 2005;173:489-95.

Organization WH. World report on ageing and health2015.

Cesari M, Araujo de Carvalho I, Amuthavalli Thiyagarajan J, et al. Evidence for the Domains Supporting the Construct of Intrinsic Capacity. The Journals of Gerontology: Series A 2018;73:1653-60.

Ángel Rodríguez-Laso MÁCM, Inés García Sánchez, Leocadio Rodríguez Mañas, Roberto Bernabei, Branko Gabrovec, Anne Hendry, Aaron Liew, Rónán O'Caoimh, Regina Roller-Wirnsberger, Eleftheria Antoniadou, Ana María Carriazo, Lucia Galluzzo, Josep Redón, Tomasz Targowski, on behalf of all ADVANTAGE Joint Action partners. State of the art report on the prevention and management of frailty: ADVANTAGE; 2018.

(SEGG) PASSEdGyG, Andalucía JMEACAd, (AEC) RJVAdEC, et al. Documento de consenso sobre prevención de fragilidad y caídas en la persona mayor estrategia de promoción de la salud y prevención en el SNS. In: Gobierno de España. Ministerio de Sanidad SSeIDgdsp, calidad e innovación, ed.2014

Garcia-Garcia FJ, Gutierrez Avila G, Alfaro-Acha A, et al. The prevalence of frailty syndrome in an older population from Spain. The Toledo Study for Healthy Aging. The journal of nutrition, health & aging 2011;15:852-6.

Alcala MV, Puime AO, Santos MT, Barral AG, Montalvo JI, Zunzunegui MV. [Prevalence of frailty in an elderly Spanish urban population. Relationship with comorbidity and disability]. Aten Primaria 2010;42:520-7.

Fernandez-Bolaños M, Otero Á, Zunzunegui MV, et al. SEX DIFFERENCES IN THE PREVALENCE OF FRAILTY IN A POPULATION AGED 75 AND OLDER IN SPAIN. Journal of the American Geriatrics Society 2008;56:2370-1.

Formiga F, Ferrer A, Chivite D, Montero A, Sanz H, Pujol R. Utility of geriatric assessment to predict mortality in the oldest old: the Octabaix study 3-year follow-up. Rejuvenation research 2013;16:279-84.

Jurschik P, Nunin C, Botigue T, Escobar MA, Lavedan A, Viladrosa M. Prevalence of frailty and factors associated with frailty in the elderly population of Lleida, Spain: the FRALLE survey. Archives of gerontology and geriatrics 2012;55:625-31.

Dent E, Kowal P, Hoogendijk EO. Frailty measurement in research and clinical practice: A review. European journal of internal medicine 2016;31:3-10.

Zheng Z, Guan S, Ding H, et al. Prevalence and Incidence of Frailty in Community-Dwelling Older People: Beijing Longitudinal Study of Aging II. Journal of the American Geriatrics Society 2016;64:1281-6.

Checa-Lopez M, Oviedo-Briones M, Pardo-Gomez A, et al. FRAILTOOLS study protocol: a comprehensive validation of frailty assessment tools to screen and diagnose frailty in different clinical and social settings and to provide instruments for integrated care in older adults. BMC Geriatr 2019;19:86.

Abellan van Kan G, Rolland Y, Andrieu S, et al. Gait speed at usual pace as a predictor of adverse outcomes in community-dwelling older people an International Academy on Nutrition and Aging (IANA) Task Force. The journal of nutrition, health & aging 2009;13:881-9.

Studenski S, Perera S, Patel K, et al. Gait speed and survival in older adults. Jama 2011;305:50-8.

Cesari M, Kritchevsky SB, Penninx BW, et al. Prognostic value of usual gait speed in well-functioning older people--results from the Health, Aging and Body Composition Study. Journal of the American Geriatrics Society 2005;53:1675-80.

Ángel Rodríguez-Laso MÁCM, Inés García Sánchez, Leocadio Rodríguez Mañas, et al, on behalf of all ADVANTAGE Joint Action partners. . State of the art report on the prevention and management of frailty. .

Guralnik JM, Simonsick EM, Ferrucci L, et al. A Short Physical Performance Battery Assessing Lower Extremity Function: Association With Self-Reported Disability and Prediction of Mortality and Nursing Home Admission. Journal of gerontology 1994;49:M85-M94.

Mitnitski AB, Mogilner AJ, Rockwood K. Accumulation of deficits as a proxy measure of aging. TheScientificWorldJournal 2001;1:323-36.

Alonso Bouzon C, Carnicero JA, Turin JG, Garcia-Garcia FJ, Esteban A, Rodriguez-Manas L. The Standardization of Frailty Phenotype Criteria Improves Its Predictive Ability: The Toledo Study for Healthy Aging. Journal of the American Medical Directors Association 2017;18:402-8.

Garcia-Garcia FJ, Carcaillon L, Fernandez-Tresguerres J, et al. A new operational definition of frailty: the Frailty Trait Scale. Journal of the American Medical Directors Association 2014;15:371.e7-.e13.

Soysal P, Isik AT, Carvalho AF, et al. Oxidative stress and frailty: A systematic review and synthesis of the best evidence. Maturitas 2017;99:66-72.

Calvani R, Marini F, Cesari M, et al. Biomarkers for physical frailty and sarcopenia: state of the science and future developments. Journal of cachexia, sarcopenia and muscle 2015;6:278-86.

Vellas B, Cesari M, Li J. White book on frailty. 2017. IAGG GARN Google Scholar 2017.

Abizanda P, Romero L, Sanchez-Jurado PM, Martinez-Reig M, Gomez-Arnedo L, Alfonso SA. Frailty and mortality, disability and mobility loss in a Spanish cohort of older adults: the FRADEA study. Maturitas 2013;74:54-60.

Bock J-O, König H-H, Brenner H, et al. Associations of frailty with health care costs–results of the ESTHER cohort study. BMC health services research 2016;16:128.

Casas Herrero A, Cadore EL, Martinez Velilla N, Izquierdo Redin M. Physical exercise in the frail elderly: an update. Revista espanola de geriatria y gerontologia 2015;50:74-81.

Rodriguez-Mañas L, Fried LP. Frailty in the clinical scenario. The Lancet 2015;385:e7-e9.

Palella FJ DK, Moorman AC, Loveless MO, Fuhrer J, Satten GA, et al. . Declining morbidity and mortality in an ambulatory HIV-infected population. N Engl J Med 1998;338:853-60.

Guaraldi G OG, Zona S, Menozzi M, Carli F, Garlassi E, et al. Premature age-related comorbidities among HIV-infected persons compared with the general population. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2011 53:1120-6.

Rodger AJ LR, Schechter M, Deeks S, Amin J, Gilson R, et al. Mortality in well controlled HIV in the continuous antiretroviral therapy arms of the SMART and ESPRIT trials compared with the general population. AIDS (London, England) 2013;27:973-9.

Erlandson KM, Karris MY. HIV and Aging: Reconsidering the Approach to Management of Comorbidities. Infectious disease clinics of North America 2019;33:769-86.

Desquilbet L JL, Fried LP, Phair JP, Jamieson BD, Holloway M, et al. HIV-1 infection is associated with an earlier occurrence of a phenotype related to frailty. J Gerontol A Biol Sci Med Sci 2007;62:1279-86.

Lang PO MJ, Zekry D. Frailty syndrome: a transitional state in a dynamic process. Gerontology 2009;55:539-49.

Guaraldi G BT, Zona S, Stentarelli C, Carli F, Malagoli A, et al. A frailty index predicts survival and incident multimorbidity independent of markers of HIV disease severity. AIDS (London, England) 2015;29:1633-41.

Erlandson KM PJ, Abdo M, Robertson K, Ellis RJ, Koletar SL, et al. Frailty, Neurocognitive Impairment, or Both in Predicting Poor Health Outcomes Among Adults Living with HIV. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2018.

Tassiopoulos K AM, Wu K, Koletar SL, Palella FJ, Jr., Kalayjian R, et al. Frailty is strongly associated with increased risk of recurrent falls among older HIV-infected adults: a prospective cohort study. AIDS (London, England) 2017.

Erlandson KM AA, Jankowski CM, Duong S, MaWhinney S, Kohrt WM, et al. Risk factors for falls in HIV-infected persons. J Acquir Immune Defic Syndr 2012;61:484-9.

Kelly SG WK, Tassiopoulos K, Erlandson KM, Koletar SL, Palella FJ. Frailty is an independent risk factor for mortality, cardiovascular disease, bone disease and diabetes among aging adults with HIV. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2019;69 (8):1370-6.

Allavena C, Hanf M, Rey D, et al. Antiretroviral exposure and comorbidities in an aging HIV-infected population: The challenge of geriatric patients. PloS one 2018;13:e0203895.

Petit N, Enel P, Ravaux I, et al. Frail and pre-frail phenotype is associated with pain in older HIV-infected patients. Medicine 2018;97:e9852.

Franconi I, Theou O, Wallace L, et al. Construct validation of a Frailty Index, an HIV Index and a Protective Index from a clinical HIV database. PloS one 2018;13:e0201394.

Piggott DA VR, Mehta SH et al. Frailty, inflammation, and mortality among persons aging with HIV infection and injection drug use. J Gerontol A Biol Sci Med Sci 2015;70:1542–7.

Rees HC IV, McCracken P, Smith S, Georgescu A, Zangeneh T, Mohler J, Klotz SA. Measuring frailty in HIV-infected individuals. Identification of frail patients is the first step to amelioration and reversal of frailty. J Vis Exp 2013;77.

Erlandson KM AA, Jankowski CM, Duong S, Mawhinney S, Kohrt WM, Campbell TB. Comparison of functional status instruments in HIV-infected adults on effective antiretroviral therapy. HIV Clin Trials 2012;13 (6):324-34.

Gustafson DR, Shi Q, Thurn M, et al. Frailty and Constellations of Factors in Aging HIV-infected and Uninfected Women--The Women's Interagency HIV Study. The Journal of frailty & aging 2016;5:43-8.

Branas F, Jimenez Z, Sanchez-Conde M, et al. Frailty and physical function in older HIV-infected adults. Age Ageing 2017;46:522-6.

Abizanda P Sn-JP, Romero L et al. . Prevalence of frailty in a Spanish elderly population: the Frailty and Dependence in Albacete Study. J Am Geriatr Soc 2011;59:1356–9.

Smit M BK, Geerlings S, Smit C, Thyagarajan K, Sighem Av, de Wolf F, Hallett TB. Future challenges for clinical care of an ageing population infected with HIV: a modelling study. Lancet Infect Dis 2015;15 (7):810-8.

Pathai S BH, Landay AL, High KP. Is HIV a model of accelerated or accentuated aging? J Gerontol A Biol Sci Med Sci 2014;69:833–42.

Greene M CK, Valcour V, Miao Y, Madamba J, Lampiris H, Cenzer IS, Martin J, Deeks SG. Geriatric Syndromes in Older HIV-Infected Adults. J Acquir Immune Defic Syndr 2015;69:161-7.

Fukui SM, Piggott DA, Erlandson KM. Inflammation Strikes Again: Frailty and HIV. Current HIV/AIDS reports 2018;15:20-9.

Guaraldi G ZS, Silva AR, Menozzi M, Dolci G, Milic J, Carli F, Mussini C. The dynamic association between Frailty, CD4 and CD4/CD8 ratio in people aging with HIV. PloS one 2019;14 (2).

Sánchez-Conde M R-CJ, Dronda F, López JC, Jiménez Z, Berenguer J, Pérez-Elías MJ, Moreno S, Rodés B, Brañas F. Frailty phenotype: a clinical marker of age acceleration in the older HIV-infected population. Epigenomics 2019;11 (5):501-9.

Nozza S, Malagoli A, Maia L, et al. Antiretroviral therapy in geriatric HIV patients: the GEPPO cohort study. The Journal of antimicrobial chemotherapy 2017;72:2879-86.

Publicado
29-11-2019
Sección
Mesa redonda de VIH